Summary
Terry Cook FMedSci is Professor of Renal Pathology at Imperial College. He is also Consultant Renal Pathologist in North West London Pathology. He is Past-President of the Renal Pathology Society.
Publications
Journals
Barbour SJ, Coppo R, Er L, et al.Barbour SJ, Coppo R, Er L, Pillebout E, Russo ML, Alpers CE, Fogo AB, Ferrario F, Jennette JC, Roberts ISD, Cook HT, Ding J, Su B, Zhong X, Fervenza FC, Zand L, Peruzzi L, Lucchetti L, Katafuchi R, Shima Y, Yoshikawa N, Ichikawa D, Suzuki Y, Murer L, Wyatt RJ, Park C, Nelson RD, Narus JH, Wenderfer S, Geetha D, Daugas E, Monteiro RC, Nakatani S, Mastrangelo A, Nuutinen M, Koskela M, Weber LT, Hackl A, Pohl M, Pecoraro C, Tsuboi N, Yokoo T, Takafumi I, Fujimoto S, Conti G, Santoro D, Materassi M, Zhang H, Shi S, Liu Z-H, Tesar V, Maixnerova D, Avila-Casado C, Bajema I, Barreca A, Becker JU, Comstock JM, Cornea V, Eldin K, Hernandez LH, Hou J, Joh K, Lin M, Messias N, Muda AO, Pagni F, Diomedi-Camassei F, Tokola H, D'Armiento M, Seidl M, Rosenberg A, Sannier A, Soares MF, Wang S, Zeng C, Haas M close, 2024, Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis., Clin J Am Soc Nephrol, Vol:19, Pages:438-451
Tam FWK, Tumlin J, Barratt J, et al.Tam FWK, Tumlin J, Barratt J, Rovin BH, Roberts ISD, Roufosse C, Cook HT, Bhangal G, Brown AL, Busch M, Dudhiya F, Duliege A-M, Fraser DJ, Gale DP, Huang C-C, Lai P-C, Lee M, Masuda ES, McAdoo SP, Rosenkranz AR, Sommerer C, Sunder-Plassmann G, Szeto C-C, Tang SCW, Williamson DE, Willcocks L, Vielhauer V, Kim MJ, Todd L, Zayed H, Tong-Starksen S, Lafayette R close, 2023, Randomized trial on the effect of an oral spleen tyrosine kinase inhibitor in the treatment of IgA nephropathy, Kidney International Reports, Vol:8, ISSN:2468-0249, Pages:2546-2556
Nester C, Appel GB, Bomback AS, et al.Nester C, Appel GB, Bomback AS, Bouman KP, Cook HT, Daina E, Dixon BP, Rice K, Najafian N, Hui J, Podos SD, Langman CB, Lightstone L, Parikh S, Pickering MC, Sperati CJ, Trachtman H, Tumlin J, de Vries APJ, Wetzels JFM, Remuzzi G close, 2023, Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies (vol 53, pg 687, 2023), American Journal of Nephrology, ISSN:0250-8095
Nester C, Appel GB, Bomback AS, et al.Nester C, Appel GB, Bomback AS, Bouman KP, Cook HT, Daina E, Dixon BP, Rice K, Najafian N, Hui J, Podosh SD, Langman CB, Lightstone L, Parikh SV, Pickering MC, Sperati CJ, Trachtman H, Tumlin J, de Vries APJ, Wetzels JFM, Remuzzi G close, 2023, Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies, American Journal of Nephrology, Vol:53, ISSN:0250-8095, Pages:687-700
Podos SD, Trachtman H, Appel GB, et al.Podos SD, Trachtman H, Appel GB, Bomback AS, Dixon BP, Wetzels JFM, Cook HT, Parikh SV, Pickering MC, Tumlin J, Langman CB, Lightstone L, Sperati CJ, Daina E, Bouman KP, Rice K, Thanassi JA, Huang M, Nester C, Remuzzi G close, 2023, Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan, American Journal of Nephrology, Vol:53, ISSN:0250-8095, Pages:675-686
More Publications
